Monday, February 05, 2024 3:56:28 PM
SOHM, Inc.
@sohminc
We are excited to announce that our company will participate in the American Association for Cancer Research (AACR) annual meeting in San Diego from April 5 to April 10, 2024.
At this internationally attended meeting, we will present our innovative gene-editing system, ABBIE, and its potential in cancer research to the scientific community and media covering the conference.
The abstract of our poster presentation will be published on the AACR website (http://aacr.org) on March 22, 2024.
Our preliminary focus in this project is cancer, but our technology has utilities in many areas of medicine and bioscience where genome editing has great potential. As we progress in this work, we plan to add highly significant research and product developments for various industries in biotech, medicine and agriculture.
We are very proud of our company’s progress to date, our entire research team, including but not limited to Dr. David Aguilar, PhD and our Research Scientist, Alfred Gallegos, and our contributions to genome editing, cell engineering, and the biomedical and other biotech sectors.
Baron Night
CEO
$SHMN
Recent SHMN News
- Gene Editing Company Joins Forces to Advance Gene Therapy • AllPennyStocks.com • 04/01/2024 03:46:00 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM